|
|||||
|
|
| 蛋白质组学分析在淋巴瘤中的应用进展 | |
| 引用本文： | 马瑞娟,刘丽宏. 蛋白质组学分析在淋巴瘤中的应用进展[J]. 国际输血及血液学杂志, 2017, 40(4). DOI: 10.3760/cma.j.issn.1673-419X.2017.04.010 |
| 作者姓名： | 马瑞娟 刘丽宏 |
| 作者单位： | 河北医科大学第四医院河北省淋巴瘤诊疗中心,石家庄,050000 |
| 摘 要： | 蛋白质组学分析已经广泛应用于多种肿瘤的临床研究,用于发现可以应用于临床的潜在生物学标志物.近年,与淋巴瘤相关的蛋白质组学分析研究也正在进行中,主要涉及淋巴瘤的发病机制、诊断、分型、治疗及预测预后等方面.为了使相关临床工作者更好地了解蛋白质组学分析及其应用价值,笔者拟就蛋白质组学分析在淋巴瘤中的应用进展进行综述. |
| 关 键 词： | 蛋白质组学 淋巴瘤 诊断 药物疗法 预后 |
Application progress of proteomics analysis in lymphoma |
|
| Ma Ruijuan,Liu Lihong. Application progress of proteomics analysis in lymphoma[J]. International Journal of Blood Tranfusion and Hematology, 2017, 40(4). DOI: 10.3760/cma.j.issn.1673-419X.2017.04.010 | |
| Authors: | Ma Ruijuan Liu Lihong |
| Abstract: | Proteomics analysis has been widely used in clinical studies of various tumors for the discovery of potential biomarkers that can be applied to clinical.Recently,lymphoma-related proteomics analysis is also ongoing,mainly involved with the pathogenesis,diagnosis,classification,treatment and prognosis of lymphoma,and so on.In order to make a better understanding of proteomics analysis and its application value,this article reviews literatures on proteomics analysis in lymphoma. |
| Keywords: | Proteomics Lymphoma Diagnosis Drug therapy Prognosis |
| 本文献已被 万方数据 等数据库收录！ | |